V.HEM
|
Someone leaked something this just didnt go up on a whim . Company had to...
|
V.HEM
|
Yes The trail that aspire left was full of crooked moves . Yes I firmly...
|
V.HEM
|
I have read 98 of the 187 pages so far and my take is that Aspire and all...
|
V.HEM
|
Well what do you know? Guess the public offering got filled eh , and in a...
|
V.HEM
|
No news coming for awhile insider just bought. Probably trying to stabilize...
|
V.HEM
|
As long as Peter Lacey does not buy or sell with in 6 months of material...
|
V.HEM
|
I like Peter Lacey with this company , contribution with his buying gives...
|
V.HEM
|
I wouldn't be surprised to see a partnership deal made before trial...
|
V.HEM
|
How can you find out when the patents were issued.
|
V.HEM
|
This company will not need a phase 3 , so they are that much closer to...
|
V.HEM
|
On December 1 the CEO said the results would be released in 30 to 45 days...
|
V.HEM
|
The offering was for $ 2.75 million and you could invest up to $15,000 . It...
|
V.HEM
|
There will be no phase 3 . They are going from phase 2 to licensing...
|
V.HEM
|
For the new posters of this company you need to look into the history. The...
|
V.HEM
|
I asked the CEO about up listing and he said probably the NasDAQ but...
|
V.HEM
|
I was informed that we do not need a phase 3 trial and that licensing...
|
V.HEM
|
Regenocyte was a clinic that treated >150 patients using ACP as the...
|
V.HEM
|
Just sent Smeenk an email. Will let everyone know if I get a reply.
|
V.HEM
|
Thanks for the information , I will try to contact hemostemix and see if they...
|
V.HEM
|
Is Regenocyte part of Hemodtemix or is it another company ? Referring to...
|